Entera Bio Ltd
For the period ended Mar 31, 2024. Filed May 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 10, 2024
ENTX$3.25+3.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PART I – FINANCIAL INFORMATION Item 1. Financial Statements
PART I.
ITEM 1. FINANCIAL STATEMENTS
UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
AS OF MARCH, 31 2024
TABLE OF CONTENTS
| Page | |
|---|---|
| CONDENSED CONSOLIDATED FINANCIAL STATEMENTS: | |
| Condensed Consolidated Balance Sheets (unaudited) | 4 |
| Condensed Consolidated Statements of Operations (unaudited) | 5 |
| Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited) | 6 |
| Condensed Consolidated Statements of Cash Flows (unaudited) | 7 |
| Notes to the Consolidated Financial Statements (unaudited) | 8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.